Clincosm LogoSign in Get a demo

gastroesophageal junction carcinoma

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nivolumab in Treatment of Early Stage Esophageal or

Not yet recruiting
  • Esophageal Carcinoma
  • Gastroesophageal Junction Carcinoma
    • Louisville, Kentucky
    • +2 more
    Mar 21, 2023

    Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma Trial in United States

    Not yet recruiting
    • Esophageal Adenocarcinoma
    • +2 more
    • Palo Alto, California
    • +5 more
    Jan 12, 2023

    NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

    Recruiting
    • Non-small Cell Lung Cancer
    • +11 more
    • Birmingham, Alabama
    • +32 more
    Jan 4, 2023

    ResiduAl Cancer With Liquid Biopsy Evaluation

    Recruiting
    • Bladder Carcinoma
    • +14 more
    • Guardant Reveal
    • Redwood City, California
      Redwood City
    Sep 7, 2022

    Carcinoma, Non-Small Cell Lung, HER2 Negative Breast Tumors, Ovarian Tumors Trial in Worldwide (SGN-STNV)

    Recruiting
    • Carcinoma, Non-Small Cell Lung
    • +11 more
    • Los Angeles, California
    • +16 more
    Aug 15, 2022

    Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in China, United States (TJ033721)

    Recruiting
    • Solid Tumor
    • +6 more
    • Orange, California
    • +17 more
    Aug 9, 2022

    Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Orange (Oxaliplatin, Capecitabine, Celecoxib)

    Terminated
    • Gastric Carcinoma
    • Gastroesophageal Junction Carcinoma
    • Orange, California
      Chao Family Comprehensive Cancer Center
    Feb 6, 2019